McGarrell Reilly has announced that PCI Pharma Services, a pharmaceutical contract development and manufacturing organization (CDMO), has signed a 25-year lease agreement and will construct a new industrial facility at CityNorth Business Campus in Stamullen, Co. Meath, Ireland. With direct access to the M1 motorway, the development offers state-of-the-art facilities, making it an ideal choice for PCI’s continued growth in the region.

For PCI, the forthcoming facility will provide 82,000 square feet of additional production and services space alongside its existing 45,000 square foot facility. Per PCI’s commitment to bolstering eco-friendliness, the new plant will offer high sustainability credentials including a targeted LEED Gold certification, A3 BER, and rainwater harvesting. The building will be completed in the first quarter of 2025, with PCI then undertaking an extensive fit out for commercial pharmaceutical packaging operations, one of its key business segments.

PCI supports the development, manufacturing, and packaging of critical medicines across the drug product lifecycle, from early phase clinical trials through product launch and commercial market supply. The company’s facilities in Ireland provide comprehensive packaging solutions for oral solid dose (tablets and capsules) and sterile injectable dosage forms. The new plant will leverage the assets at PCI’s existing CityNorth facility, combining technology with personnel expertise to help its biopharma clients achieve quality manufacturing and speed to market for life-changing medicines.

CityNorth Business Campus opened in 2006 with a variety of high-quality commercial business sites. The campus is situated on the M1 motorway at junction 7 offering occupier’s access to the Port Tunnel/M50 network within 15 minutes, and Belfast City Center within 90 minutes. Occupiers of the Business Campus include Circle K service station and a range of commercial businesses.

“We are delighted to welcome PCI’s further expansion in the campus,” said Sean Reilly, founder of McGarrell Reilly. “Their decision to locate here and substantially grow their operations is a great endorsement of CityNorth Business Campus. We are confident that PCI will continue to thrive in this exceptional campus environment and that CityNorth will continue to attract further high-profile tenants.”

“This strategic expansion of our commercial packaging operations is an investment that will provide growth in this key area close to Dublin over the next 3-5 years,” said James McDermott, general manager, PCI Pharma Services, Ireland. “The enhanced capabilities and capacity at the PCI CityNorth campus will ensure that we remain the go-to CDMO for innovative commercial packaging technology solutions for pharmaceutical product launches and ongoing market supply. We look forward to working with our long-term contractor partners and seeing the site develop over the coming months to help us meet our growing client demands.”

Global head of life sciences at IDA Ireland, Rachel Shelly said, “This expansion by PCI, a provider of sterile and high potent drug development, clinician trial services and commercial packaging for the pharma and biopharma sectors, is excellent news for county Meath and indeed the entire mid-east region. PCI is an established member of the region’s growing life science cluster, and this latest announcement reinforces their commitment to Ireland. I wish the team continued success as they grow their operations here.”